The South Africa Brugada Syndrome Market was valued at $7.8 Mn in 2023 and is predicted to grow at a CAGR of 9.03% from 2023 to 2030, to $14.3 Mn by 2030. The key drivers of the market include growing prevalence of cardiovascular diseases, aging population, and advancements in genetic testing. The prominent players of the South Africa Brugada Syndrome Market are Sun Pharma, Cipla, Bayer, Sanofi, Aspen Pharmacare, Astellas, and Medtronic, among others.
Saudi Arabia Blood Disorder Therapeutics Market valued at $228 Mn in 2022, projected to reach $454 Mn by 2030 with a 9% CAGR. Several factors are converging to cause market expansion, such as a young and expanding population, government initiatives supporting improved healthcare accessibility, advocacy groups raising awareness about advanced therapies, and digital healthcare integration. The Saudi Arabia Blood Disorder Therapeutics Market encompasses various players across different segments, including Pfizer, Roche, Takeda Pharmaceuticals, Novartis, Sanofi, Novo Nordisk, Bayer, Jamjoom Pharma, Tabuk Pharma, Tamer Pharma etc, among various others.
India Clinical Nutrition for Chronic Kidney Diseases Market was valued at $28.60 Mn in 2023 and is predicted to grow at a CAGR of 9.03% from 2023 to 2030, to $52.30 Mn by 2030. The key drivers of this industry include rising CKD prevalence, increased awareness, and technological advancements. The industry is primarily dominated by Abbott Nutrition, Pfizer Inc., Bayer AG, and Nestlé Health Science among others.
France Dental Endodontics Market was valued at $48.10 Mn in 2023 and is predicted to grow at a CAGR of 3.3% from 2023 to 2030, to $60.40 Mn by 2030. The key drivers of this industry include a growing focus on oral health awareness, an aging population, and technological advancement. The industry is primarily dominated by Coltene, Dentsply Sirona, FKG Dentaire, and Ultradent Products among others.
The India Brugada Syndrome Market was valued at $21.8 Mn in 2023 and is predicted to grow at a CAGR of 10.8% from 2023 to 2030, to $44.7 Mn by 2030. The key drivers of the market include growing prevalence of cardiovascular diseases, advancements in genetic testing, and aging population. The prominent players of the India Brugada Syndrome Market are Intas, Sun Pharmaceuticals, Cipla, Divi's Lab, Dr. Reddy's Laboratories, and Zydus Lifesciences, among others.
Indonesia Blood Disorder Therapeutics Market valued at $80 Mn in 2022, projected to reach $143 Mn by 2030 with a 7.5% CAGR. The market growth is fuelled due to certain factors such as the increasing incidence of blood disorders in Indonesia, driven by improved diagnostics and accessibility, heightened awareness, identification of genetic and environmental risk factors, and rising investments in healthcare. The Indonesia Blood Disorder Therapeutics Market encompasses various players across different segments, including Roche, Novartis, Pfizer, Bayer, BioMarin Pharmaceutical, Takeda, Kalbe Farma, Dexa Medica, Combiphar, Kimia Farma, etc, among various others.
Germany Dental Endodontics Market was valued at $64 Mn in 2023 and is predicted to grow at a CAGR of 2.5% from 2023 to 2030, to $76.10 Mn by 2030. The key drivers of this industry include a high focus on oral health, an aging population, and technological advancement. The industry is primarily dominated by Coltene, Dentsply Sirona, FKG Dentaire, and Ultradent Products among others.
The Canada Breast Pump Market was valued at $235.2 Mn in 2023 and is predicted to grow at a CAGR of 8.6% from 2023 to 2030, to $419 Mn by 2030. The key drivers of the market include the rising female workforce, product innovations, and growing consumer awareness. The prominent players in the Canada Breast Pump Market are Ameda, Avent, Evenflo, Pigeon, Playtex, and Hygeia, among others.
Kenya Blood Disorder Therapeutics Market valued at $9 Mn in 2022, projected to reach $18 Mn by 2030 with a 8.6% CAGR. The market in Kenya is fuelled due to certain factors such as the increasing prevalence of blood disorders, higher expenditure on healthcare by the government, and the rise in technological innovations leading to safer and personalized medications. The Kenya Blood Disorder Therapeutics Market encompasses various players across different segments, including Takeda, Pfizer, AstraZeneca, Sanofi, Roche, Novartis, Sun Pharmaceuticals, Regal Pharmaceuticals, Nextgen Pharmaceuticals, Transwide Pharmaceuticals etc, among various others.
Spain Dental Endodontics Market was valued at $33.80 Mn in 2023 and is predicted to grow at a CAGR of 3.3% from 2023 to 2030, to $42.40 Mn by 2030. The key drivers of this industry include rising demand for tooth preservation, an aging population, and growing dental awareness. The industry is primarily dominated by Coltene, Dentsply Sirona, FKG Dentaire, and Ultradent Products among others.
The US Breast Pump Market was valued at $1234.8 Mn in 2023 and is predicted to grow at a CAGR of 6.6% from 2023 to 2030, to $1931.5 Mn by 2030. The key drivers of the market include the rising female workforce, product innovations, and growing consumer awareness. The prominent players in the US Breast Pump Market are Magento Dr. Brown’s, Freemie, Evenflo, Nuk, Hygeia, Spectra Baby, Willow, Momcozy, and iAPOY, among others.
Mexico Blood Disorder Therapeutics Market valued at $201 Mn in 2022, projected to reach $365 Mn by 2030 with a 7.75% CAGR. Growth in the market is being driven by Mexico's increasing prevalence of age-related blood diseases, unmet medical needs of the population as well as improvements in treatments like gene and targeted therapy. The Mexico Market encompasses various players across different segments, including Takeda, Sanofi, CSL Ltd, Pfizer, Celgene Corporation, Alexion Pharmaceuticals, Amgen, Laboratorios Grin, PiSA Pharmaceutical Company, Genomma Lab Internacional, etc, among various others.
The Saudi Arabia Clinical Nutrition Market was valued at $521.4 Mn in 2023 and is projected to grow at a CAGR of 6.84% from 2023 to 2023, to $828.5 Mn by 2030. The key drivers of this industry are increasing prevalence of chronic diseases and metabolic disorders, aging population, increasing awareness of the importance of nutrition for health, product innovations and technological advancements, government initiatives and rising healthcare expenditure, rising incidence of malnutrition especially in paediatric patients which has contributed to market growth. The industry is primarily dominated by players such as Almarai, Tabuk Pharmaceuticals, Abbott Nutrition, Pfizer Inc, Nestle, Baxter International Inc., Otsuka Holdings Co., Ltd among other.
UK Dental Endodontics Market was valued at $45.50 Mn in 2023 and is predicted to grow at a CAGR of 2.3% from 2023 to 2030, to $53.40 Mn by 2030. The key drivers of this industry include rising demand for tooth preservation, an aging population, technological advancements, and increased awareness. The industry is primarily dominated by Coltene, Dentsply Sirona, FKG Dentaire, and Ultradent Products among others.
The Saudi Arabia Breast Pump Market was valued at $50 Mn in 2023 and is predicted to grow at a CAGR of 10.1% from 2023 to 2030, to $98 Mn by 2030. The key drivers of the market include the improving healthcare infrastructure, growing consumer awareness, and rising disposable incomes. The prominent players of the Saudi Arabia Breast Pump Market are Microlife, Nubeca, Nuby, Bistos, Ameda, Avent, Evenflo, Pigeon, Playtex, and Horigen.
Singapore Blood Disorder Therapeutics Market valued at $16 Mn in 2022, projected to reach $30 Mn by 2030 with a 8.1% CAGR. The market is expanding due to the rising prevalence of blood disorders brought on by aging populations and unhealthy lifestyle choices, therapeutic advancements supported by technology developments, and government programs that fund research and provide affordable therapies. The Singapore Blood Disorder Therapeutics Market encompasses various players across different segments, including Takeda, Sanofi, Novo Nordisk, CSL Ltd, Pfizer, Bayer, BioLife Sciences, Agenus, Spark Therapeutics, Abeo Therapeutics, etc, among various others.
The UAE Clinical Nutrition Market was valued at $153.3 Mn in 2023 and is projected to grow at a CAGR of 6.34% from 2023 to 2023, to $235.8 Mn by 2030. The key drivers of this industry are increasing prevalence of chronic diseases and metabolic disorders, aging population, increasing awareness of the importance of nutrition for health, product innovations and technological advancements, government initiatives and rising healthcare expenditure, rising incidence of malnutrition especially in paediatric patients which has contributed to market growth. The industry is primarily dominated by players such as BASF, B Braun, Abbott Nutrition, Pfizer Inc, Bayer AG, Nestle, Baxter International Inc., Otsuka Holdings Co., Ltd among others.
China Dental Endodontics Market was valued at $140.70 Mn in 2023 and is predicted to grow at a CAGR of 5.8% from 2023 to 2030, to $208.70 Mn by 2030. The key drivers of this industry include growing demand for cosmetic dentistry, increasing dental awareness, and expansion of dental infrastructure. The industry is primarily dominated by Coltene, Dentsply Sirona, FKG Dentaire, and Ultradent Products among others.
The UAE Breast Pump Market was valued at $14.7 Mn in 2023 and is predicted to grow at a CAGR of 9.6% from 2023 to 2030, to $27.9 Mn by 2030. The key drivers of the market include the rising female workforce, technological advancements, and consumer awareness. The prominent players of the UAE Breast Pump Market are Ardo, Nubeca, Playtex, Ameda, Avent, and Evenflo, among others.
South Africa Blood Disorder Therapeutics Market valued at $87 Mn in 2022, projected to reach $170 Mn by 2030 with a 8.37% CAGR. The key drivers include the implementation of initiatives like collaborative efforts between government agencies, NGOs, and pharmaceutical businesses, demographic factors influencing blood disorders prevalence, and the anticipation of introducing novel therapies, leading to increased research, development, and infrastructure investments in the field. The South Africa Blood Disorder Therapeutics Market encompasses various players across different segments, including Takeda, Pfizer, AstraZeneca, Sanofi, Aspen, Adcock Ingram, Eisai, BGM, Gilead Sciences, Sunrise Pharmaceuticals etc, among various others.
The Brazil Clinical Nutrition Market was valued at $766.8 Mn in 2023 and is projected to grow at a CAGR of 6.34% from 2023 to 2023, to $1179 Mn by 2030. The key drivers of this industry are increasing prevalence of chronic diseases and metabolic disorders, aging population, increasing awareness of the importance of nutrition for health, product innovations and technological advancements, government initiatives and rising healthcare expenditure, rising incidence of malnutrition especially in paediatric patients which has contributed to market growth. The industry is primarily dominated by players such as Oceandrop, Vitafor, Prodiet Medical Nutrition, Abbott Nutrition, Pfizer Inc, Nestle, Mead Johnson & Company, LLC among others.
Indonesia Dental Endodontics Market was valued at $10.50 Mn in 2023 and is predicted to grow at a CAGR of 4.3% from 2023 to 2030, to $14.10 Mn by 2030. The key drivers of this industry include a rising awareness of oral health, a growing geriatric population, and an expansion of dental tourism. The industry is primarily dominated by Coltene, Dentsply Sirona, FKG Dentaire, and Ultradent Products among others.
The Brazil Breast Pump Market was valued at $73.5 Mn in 2023 and is predicted to grow at a CAGR of 9.6% from 2023 to 2030, to $139.6 Mn by 2030. The key drivers of the market include improving healthcare infrastructure, growing consumer awareness, and rising disposable incomes. The prominent players in the Brazil Breast Pump Market are Ardo, CA-MI, Lansinoh, Microlife, Nubeca, and Nuby, among others.
Vietnam Blood Disorder Therapeutics Market valued at $67 Mn in 2022, projected to reach $122 Mn by 2030 with a 7.73% CAGR. The key drivers of the market in Vietnam include the increasing prevalence of diseases such as aplastic anemia, hemophilia, and thalassemia due to advancements in diagnostics, lifestyle changes, and genetic susceptibility, supported by government initiatives prioritizing healthcare improvement in the country. The Vietnam Blood Disorder Therapeutics Market encompasses various players across different segments, including Takeda, Sanofi, Novo Nordisk, CSL Ltd, Pfizer, Bayer, Sun Pharma, Teva, Ha Tay Pharma, Imexpharm, etc, among various others.
The Mexico Clinical Nutrition Market was valued at $460.1 Mn in 2023 and is projected to grow at a CAGR of 5.59% from 2023 to 2023, to $673.2 Mn by 2030. The key drivers of this industry are increasing prevalence of chronic diseases and metabolic disorders, aging population, increasing awareness of the importance of nutrition for health, product innovations and technological advancements, government initiatives and rising healthcare expenditure, rising incidence of malnutrition especially in paediatric patients which has contributed to market growth. The industry is primarily dominated by players such Amway, Herbalife, and Nestle.